Variation in a Repeat Sequence Determines Whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Is Pathogenic or Benign | Zendy

Joshua D. Groman | Zendy; Timothy Hefferon | Zendy; Teresa Casals | Zendy; L. Bassas | Zendy; Xavier Estivill | Zendy; Marie des Georges | Zendy; Caroline Guittard | Zendy; Monika Koudová | Zendy; M. Daniele Fallin | Zendy; Krisztiémeth | Zendy; György Fekete | Zendy; L Kádasi | Zendy; Ken Friedman | Zendy; Martin Schwarz | Zendy; Cristina Bombieri | Zendy; Pier Franco Pignatti | Zendy; Emmanuel Kanavakis | Zendy; Maria Tzetis | Zendy; Marianne Schwartz | Zendy; Giuseppe Novelli | Zendy; Maria Rosaria D’Apice | Zendy; Agnieszka SobczyńskaTomaszewska | Zendy; Jerzy Bal | Zendy; Manfred Stuhrmann | Zendy; Milan Maçek | Zendy; Mireille Claustres | Zendy; Garry R. Cutting | Zendy

Open Access

Variation in a Repeat Sequence Determines Whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene Is Pathogenic or Benign

Author(s) -

Joshua D. Groman,

Timothy Hefferon,

Teresa Casals,

L. Bassas,

Xavier Estivill,

Marie des Georges,

Caroline Guittard,

Monika Koudová,

M. Daniele Fallin,

Krisztiémeth,

György Fekete,

L Kádasi,

Ken Friedman,

Martin Schwarz,

Cristina Bombieri,

Pier Franco Pignatti,

Emmanuel Kanavakis,

Maria Tzetis,

Marianne Schwartz,

Giuseppe Novelli,

Maria Rosaria D’Apice,

Agnieszka SobczyńskaTomaszewska,

Jerzy Bal,

Manfred Stuhrmann,

Milan Maçek,

Mireille Claustres,

Garry R. Cutting

Publication year - 2004

Publication title -

carolina digital repository (university of north carolina at chapel hill)

Language(s) - English

DOI - 10.17615/3dq7-rw27

Subject(s) - cystic fibrosis transmembrane conductance regulator , regulator , transmembrane protein , sequence (biology) , gene , cystic fibrosis , conductance , genetics , biology , computational biology , medicine , mathematics , combinatorics , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research